Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib

Background and Aims: We sought to determine whether six commonly used immunosuppressive regimens were associated with lower antibody responses after seasonal influenza vaccination in patients with inflammatory bowel disease [IBD]. <...

Täydet tiedot

Bibliografiset tiedot
Päätekijät:	Liu, Z, Alexander, JL, Eng, KY, Ibraheim, H, Anandabaskaran, S, Saifuddin, A, Constable, L, Seoane, RC, Bewshea, C, Nice, R, D'Mello, A, Jones, GR, Balarajah, S, Fiorentino, F, Sebastian, S, Irving, PM, Hicks, LC, Williams, HRT, Kent, AJ, Linger, R, Parkes, M, Kok, K, Patel, KV, Teare, JP, Altmann, DM, Boyton, RJ, Hart, AL, Lees, CW, Goodhand, JR, Kennedy, NA, Pollock, KM, Ahmad, T, Powell, N
Muut tekijät:	VIP study investigators
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Oxford University Press 2023

Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib

Samankaltaisia teoksia